Ironsides Asset Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-35,907
Closed -$2.25M 76
2016
Q4
$2.25M Buy
35,907
+1,743
+5% +$106K 0.61% 41
2016
Q3
$2.15M Sell
34,164
-98
-0.3% -$6.34K 0.58% 39
2016
Q2
$2.12M Buy
34,262
+8,605
+34% +$524K 0.65% 32
2016
Q1
$1.47M Buy
+25,657
New +$1.43M 0.37% 59

Other funds holding ABBV

Ironsides Asset Advisors's ABBV Position: Q1 2017 in Review

Ironsides Asset Advisors sold out of AbbVie (ABBV) in Q1 2017, closing a stake of 35,907 shares — an estimated $2.25M sold.

Ironsides Asset Advisors first reported a position in ABBV in Q1 2016 and held it in 4 quarters. The position peaked at $2.25M in Q4 2016. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • Ironsides Asset Advisors reported no remaining AbbVie position as of Q1 2017 after selling out during the quarter.
  • Ironsides Asset Advisors sold 35,907 AbbVie shares in Q1 2017, an estimated $2.25M.
  • Ironsides Asset Advisors first reported a position in AbbVie in Q1 2016 and held it in 4 quarters.
  • Ironsides Asset Advisors's AbbVie position peaked at $2.25M in Q4 2016.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Ironsides Asset Advisors's 13F filing for Q1 2017, filed 10 May 2017.